Cholestasis Global Clinical Trials Review, H2, 2018

2018-12-31
Cholestasis Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Cholestasis Global Clinical Trials Review, H2, 2018” provides an overview of Cholestasis clinical trials scenario. This report...

Cancer Anorexia-Cachexia Syndrome Global Clinical Trials Review, H2, 2018

2018-12-31
Cancer Anorexia-Cachexia Syndrome Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Cancer Anorexia-Cachexia Syndrome Global Clinical Trials Review, H2, 2018” provides an overview of Cancer...

Chicken Pox Global Clinical Trials Review, H2, 2018

2018-12-31
Chicken Pox Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Chicken Pox Global Clinical Trials Review, H2, 2018” provides an overview of Chicken Pox clinical trials scenario. This report...

Chondrosarcoma Global Clinical Trials Review, H2, 2018

2018-12-31
Chondrosarcoma Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Chondrosarcoma Global Clinical Trials Review, H2, 2018” provides an overview of Chondrosarcoma clinical trials scenario. This...

Candidiasis Global Clinical Trials Review, H2, 2018

2018-12-31
Candidiasis Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Candidiasis Global Clinical Trials Review, H2, 2018” provides an overview of Candidiasis clinical trials scenario. This report...

Competitor Landscape: Sjogren’s Syndrome

2018-12-30
Competitor Landscape: Sjögren’s Syndrome Summary Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Sjögren’s Syndrome market, analysis of current & potential future...

Contraceptives: Opportunity Analysis and Forecasts to 2027

2018-12-11
Contraceptives: Opportunity Analysis and Forecasts to 2027 Summary Hormonal contraceptives are primarily used to prevent unintended pregnancy; however, some of these contraceptives are also approved or used off-label for other health conditions,...

Vaccines for Emerging Infectious Diseases: Funding, R&D, and Global Partnership Strategies

2018-12-11
Vaccines for Emerging Infectious Diseases: Funding, R&D, and Global Partnership Strategies Summary Emerging infectious diseases (EIDs) are characterized by unpredictable incidence and clinical patterns that pose unique challenges for vaccine...

PharmSource – Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars – 2018 Edition

2018-12-03
PharmSource – Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars – 2018 Edition Summary Biosimilars are drugs that are highly similar but not identical to branded “innovator” biologics: large molecule,...

Asia-Pacific Dura Substitute Procedures Outlook to 2025

2018-12-01
Asia-Pacific Dura Substitute Procedures Outlook to 2025 Summary GlobalData’s new report, Asia-Pacific Dura Substitute Procedures Outlook to 2025, provides key procedures data on the Asia-Pacific Dura Substitute Procedures. The report provides...
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy